£142.22

It has never been this cheap. We have no record of a lower price.

£142 today · cheaper than every other day in the last 3 months

Springer Regulation of Cancer Immune Checkpoints: Molecular and Cellular Mechanisms and Therapy: 1248 (Advances in Experimental Medicine and Biology, 1248)

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 77 days · 77 data points (no recent data)

Historical
Generating forecast…
£146.31 £141.81 £142.79 £143.77 £144.76 £145.74 £146.72 28 July 2026 16 August 2026 04 September 2026 23 September 2026 12 October 2026
View at Amazon ↗

Price data last checked 14 day(s) ago - will refresh soon

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 77 days • 2 price levels

Days at Price
Current Price
1 day · current 76 days 0 19 38 57 76 £142 £146 Days at Price

Price Analysis

Most common price: £146 (76 days, 98.7%)

Price range: £142 - £146

Price levels: 2 different prices over 77 days

Description
This book systematically reviews the most important findings on cancer immune checkpoints, sharing essential insights into this rapidly evolving yet largely unexplored research topic. The past decade has seen major advances in cancer immune checkpoint therapy, which has demonstrated impressive clinical benefits. The family of checkpoints for mediating cancer immune evasion now includes CTLA-4, PD-1/PD-L1, CD27/CD70, FGL-1/LAG-3, Siglec-15, VISTA (PD-1L)/VSIG3, CD47/SIRPA, APOE/LILRB4, TIGIT, and many others. Despite these strides, most patients do not show lasting remission, and some cancers have been completely resistant to the therapy. The potentially lethal adverse effects of checkpoint blockade represent another major challenge, the mechanisms of which remain poorly understood. Compared to the cancer signaling pathways, such as p53 and Ras, mechanistic studies on immune checkpoint pathways are still in their infancy. To improve the responses to checkpoint blockade therapy and limit the adverse effects, it is essential to understand the molecular regulation of checkpoint molecules in both malignant and healthy cells/tissues. This book begins with an introduction to immune checkpoint therapy and its challenges, and subsequently describes the regulation of checkpoints at different levels. In closing, it discusses recent therapeutic developments based on mechanistic findings, and outlines goals for future translational studies. The book offers a valuable resource for researchers in the cancer immunotherapy field, helping to form a roadmap for checkpoint regulation and develop safer and more effective immunotherapies.

Product Specifications
Brand
Springer
Format
paperback
ASIN
9811532680
Category
Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Internal Medicine > Diseases & Disorders
Domain
Amazon UK
Release Date
18 March 2021
Listed Since
19 February 2021

Barcode

No barcode data available

Similar Products You Might Like

A Beginner's Guide to Targeted Cancer Treatments
97% match

A Beginner's Guide to Targeted Cancer Treatments

Wiley

£41.95 04 Sep 2026
Clinical Immuno-Oncology
97% match

Clinical Immuno-Oncology

Elsevier

£92.14 22 Aug 2026
Cancer Immunotherapy: Immune Suppression and Tumor Growth
97% match

Cancer Immunotherapy: Immune Suppression and Tumor Growth

Elsevier

£77.00 12 Sep 2026
Tumor-Induced Immune Suppression: Mechanisms and Therapeutic Reversal
97% match

Tumor-Induced Immune Suppression: Mechanisms and Therapeutic Reversal

Springer

£148.21 13 Oct 2026
Progress in Cancer Immunotherapy - Springer Medical Research
97% match

Progress in Cancer Immunotherapy - Springer Medical Research

Springer

£110.37 05 Oct 2026
Immune Mediators in Cancer: Methods and Protocols: 2108 (Methods in Molecular Biology)
96% match

Immune Mediators in Cancer: Methods and Protocols: 2108 (Methods in Molecular Biology)

Humana

£92.38 11 Sep 2026
Biomarkers for Immunotherapy of Cancer: Methods and Protocols: 2055 (Methods in Molecular Biology, 2055)
96% match

Biomarkers for Immunotherapy of Cancer: Methods and Protocols: 2055 (Methods in Molecular Biology, 2055)

Humana

£110.83 22 Sep 2026
Biomarkers for Immunotherapy of Cancer: Methods and Protocols: 2055 (Methods in Molecular Biology, 2055)
96% match

Biomarkers for Immunotherapy of Cancer: Methods and Protocols: 2055 (Methods in Molecular Biology, 2055)

Humana

£156.36 12 Aug 2026
Critical Developments in Cancer Immunotherapy
96% match

Critical Developments in Cancer Immunotherapy

£421.00 01 Oct 2026
Immunotherapy in Translational Cancer Research (Translational Oncology)
96% match

Immunotherapy in Translational Cancer Research (Translational Oncology)

Wiley

£130.00 22 Aug 2026
Cancer Stem Cell Resistance to Targeted Therapy: 19 (Resistance to Targeted Anti-Cancer Therapeutics, 19)
96% match

Cancer Stem Cell Resistance to Targeted Therapy: 19 (Resistance to Targeted Anti-Cancer Therapeutics, 19)

Springer

£76.07 18 Sep 2026
Tumor Immune Microenvironment in Cancer Progression and Cancer Therapy: 1036 (Advances in Experimental Medicine and Biology, 1036)
96% match

Tumor Immune Microenvironment in Cancer Progression and Cancer Therapy: 1036 (Advances in Experimental Medicine and Biology, 1036)

Springer

£92.22 24 Sep 2026
Tumor Immunology: Methods and Protocols: 1393 (Methods in Molecular Biology, 1393)
96% match

Tumor Immunology: Methods and Protocols: 1393 (Methods in Molecular Biology, 1393)

Humana

£69.37 22 Sep 2026
Cancer Immunoprevention: Methods and Protocols: 2435 (Methods in Molecular Biology, 2435)
96% match

Cancer Immunoprevention: Methods and Protocols: 2435 (Methods in Molecular Biology, 2435)

Humana

£109.99 17 Sep 2026
Immunotherapy of Cancer: Innovative Treatment Comes of Age
96% match

Immunotherapy of Cancer: Innovative Treatment Comes of Age

Springer

£106.33 02 Oct 2026
Current Immunotherapeutic Strategies in Cancer: 214 (Recent Results in Cancer Research, 214)
96% match

Current Immunotherapeutic Strategies in Cancer: 214 (Recent Results in Cancer Research, 214)

Springer

£87.93 01 Oct 2026
Biology of T Cells - Part A (Volume 341) (International Review of Cell and Molecular Biology, Volume 341)
96% match

Biology of T Cells - Part A (Volume 341) (International Review of Cell and Molecular Biology, Volume 341)

Elsevier

£142.89 24 Sep 2026
Tumor Immunology and Cancer Therapy: 61
96% match

Tumor Immunology and Cancer Therapy: 61

CRC Press

£64.77 13 Oct 2026
Cancer Immunotherapy: Immune Suppression and Tumor Growth
96% match

Cancer Immunotherapy: Immune Suppression and Tumor Growth

Elsevier

£78.99 11 Sep 2026
Immunotherapy of Cancer: Methods and Protocols: 651 (Methods in Molecular Biology, 651)
96% match

Immunotherapy of Cancer: Methods and Protocols: 651 (Methods in Molecular Biology, 651)

Humana

£74.21 23 Sep 2026
Biology of T Cells - Part B: Volume 342 (International Review of Cell and Molecular Biology, Volume 342)
96% match

Biology of T Cells - Part B: Volume 342 (International Review of Cell and Molecular Biology, Volume 342)

Elsevier

£184.99 01 Oct 2026
Wiley A Beginner's Guide to Targeted Cancer Treatments
96% match

Wiley A Beginner's Guide to Targeted Cancer Treatments

Wiley

£44.89 26 Sep 2026
Immune Checkpoint Inhibitors in Cancer
96% match

Immune Checkpoint Inhibitors in Cancer

Elsevier

£68.09 17 Oct 2026
Human Pathogenic Microbes: Diseases and Concerns (Developments in Microbiology)
96% match

Human Pathogenic Microbes: Diseases and Concerns (Developments in Microbiology)

Elsevier

£117.77 23 Sep 2026